Uniportal and triportal video-assisted thoracoscopic lobectomy for treatment of non-small cell lung cancer: a comparative study / 中国内镜杂志
China Journal of Endoscopy
; (12): 59-63, 2017.
Article
de Zh
| WPRIM
| ID: wpr-658617
Bibliothèque responsable:
WPRO
ABSTRACT
Objective To compare the clinical effects of uniportal and triportal video-assisted thoracoscopic lobectomy in treatment of non-small cell lung cancer. Methods From January 2013 to November 2016, 141 non-small cell lung cancer patients underwent uniportal video-assisted thoracoscopic lobectomy (52 cases, uniportal group), and 89 lung cancer patients underwent triportal video-assisted thoracoscopic lobectomy (triportal group). All the cases were performed by the same surgeon. The operative time, intraoperative blood loss, lymph node dissection number, chest drainage duration, postoperative total drainage volume, hospital stay and postoperative complications were recorded and compared between the two groups. Results There were no statistical differences in lymph node dissection number, chest drainage duration, postoperative total drainage volume and postoperative complications after surgery between the uniportal group and the triportal group (P > 0.05). The mean operative time for the uniportal group and the triportal group was (196.1 ± 19.6) minutes and (162.7 ± 18.9) minutes, respectively, P = 0.000. The mean intraoperative blood loss for the uniportal group and the triportal group was (100.3 ± 13.6) ml and (176.5 ± 15.9) ml, respectively, P = 0.000. The hospital stay for the uniportal group and the triportal group was (7.5 ± 1.7) days and (9.2 ± 1.3) days, P = 0.000. Conclusion Uniportal video-assisted thoracoscopic lobectomy can achieve the same effect as triportal video-assisted thoracoscopic lobectomy, though it increased the operation time, however, it has the advantage of less surgical damage to chest wall muscles, intercostal nerves or blood vessels, shorten the postoperative hospital stay, and can be used as a safe and reliable radical surgery for non-small cell lung cancer.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
China Journal of Endoscopy
Année:
2017
Type:
Article